Academic Journal

Helicobacter pylori and risk of upper gastrointestinal bleeding among users of selective serotonin reuptake inhibitors.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: Helicobacter pylori and risk of upper gastrointestinal bleeding among users of selective serotonin reuptake inhibitors.
Συγγραφείς: Dall, Michael, Schaffalitzky de Muckadell, Ove B., Møller Hansen, Jane, Wildner-Christensen, Mette, Touborg Lassen, Annmarie, Hallas, Jesper
Πηγή: Scandinavian Journal of Gastroenterology; Sep2011, Vol. 46 Issue 9, p1039-1044, 6p, 2 Charts
Θεματικοί όροι: Serotonin uptake inhibitors, Gastrointestinal hemorrhage, Helicobacter pylori infections, Nonsteroidal anti-inflammatory agents, Case studies, Aspirin, Disease risk factors
Γεωγραφικοί όροι: Fyn (Denmark), Denmark
Περίληψη: Background. A number of studies have reported a possible association between use of selective serotonin reuptake inhibitors (SSRIs) and serious upper gastrointestinal bleeding (UGB). We conducted this case--control study to assess if Helicobacter pylori ( H. pylori) potentiates the risk of serious UGB in SSRI users. Material and methods. A population-based case--control study was conducted in the county of Funen, Denmark. Cases were 53 SSRI users with serious UGB whose H. pylori status on their bleeding date could be established. Controls ( n == 723) were selected among subjects who participated in a population H. pylori screening study, and who were users of SSRIs. Data on drug exposure and medical history were retrieved from a prescription database and the county's patient register. Confounders were controlled for by unconditional logistic regression. Results. H. pylori infection increased the risk of serious UGB in patients using SSRI with an adjusted odds ratio (OR) of 2.73 (95% confidence interval (CI), 1.17--6.36). The adjusted OR for serious UGB among users of non-steroidal anti-inflammatory drugs (NSAIDs) and acetylsalicylic acid (ASA) were 3.91 (95% CI, 2.03--7.52) and 3.00 (95% CI, 0.94--9.54), respectively. Conclusion. H. pylori infection increases the risk of SSRI-related serious UGB. [ABSTRACT FROM AUTHOR]
Copyright of Scandinavian Journal of Gastroenterology is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Βάση Δεδομένων: Complementary Index
FullText Text:
  Availability: 0
Header DbId: edb
DbLabel: Complementary Index
An: 64002589
RelevancyScore: 834
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 834.06103515625
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Helicobacter pylori and risk of upper gastrointestinal bleeding among users of selective serotonin reuptake inhibitors.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Dall%2C+Michael%22">Dall, Michael</searchLink><br /><searchLink fieldCode="AR" term="%22Schaffalitzky+de+Muckadell%2C+Ove+B%2E%22">Schaffalitzky de Muckadell, Ove B.</searchLink><br /><searchLink fieldCode="AR" term="%22Møller+Hansen%2C+Jane%22">Møller Hansen, Jane</searchLink><br /><searchLink fieldCode="AR" term="%22Wildner-Christensen%2C+Mette%22">Wildner-Christensen, Mette</searchLink><br /><searchLink fieldCode="AR" term="%22Touborg+Lassen%2C+Annmarie%22">Touborg Lassen, Annmarie</searchLink><br /><searchLink fieldCode="AR" term="%22Hallas%2C+Jesper%22">Hallas, Jesper</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: Scandinavian Journal of Gastroenterology; Sep2011, Vol. 46 Issue 9, p1039-1044, 6p, 2 Charts
– Name: Subject
  Label: Subject Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Serotonin+uptake+inhibitors%22">Serotonin uptake inhibitors</searchLink><br /><searchLink fieldCode="DE" term="%22Gastrointestinal+hemorrhage%22">Gastrointestinal hemorrhage</searchLink><br /><searchLink fieldCode="DE" term="%22Helicobacter+pylori+infections%22">Helicobacter pylori infections</searchLink><br /><searchLink fieldCode="DE" term="%22Nonsteroidal+anti-inflammatory+agents%22">Nonsteroidal anti-inflammatory agents</searchLink><br /><searchLink fieldCode="DE" term="%22Case+studies%22">Case studies</searchLink><br /><searchLink fieldCode="DE" term="%22Aspirin%22">Aspirin</searchLink><br /><searchLink fieldCode="DE" term="%22Disease+risk+factors%22">Disease risk factors</searchLink>
– Name: SubjectGeographic
  Label: Geographic Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Fyn+%28Denmark%29%22">Fyn (Denmark)</searchLink><br /><searchLink fieldCode="DE" term="%22Denmark%22">Denmark</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Background. A number of studies have reported a possible association between use of selective serotonin reuptake inhibitors (SSRIs) and serious upper gastrointestinal bleeding (UGB). We conducted this case--control study to assess if Helicobacter pylori ( H. pylori) potentiates the risk of serious UGB in SSRI users. Material and methods. A population-based case--control study was conducted in the county of Funen, Denmark. Cases were 53 SSRI users with serious UGB whose H. pylori status on their bleeding date could be established. Controls ( n == 723) were selected among subjects who participated in a population H. pylori screening study, and who were users of SSRIs. Data on drug exposure and medical history were retrieved from a prescription database and the county's patient register. Confounders were controlled for by unconditional logistic regression. Results. H. pylori infection increased the risk of serious UGB in patients using SSRI with an adjusted odds ratio (OR) of 2.73 (95% confidence interval (CI), 1.17--6.36). The adjusted OR for serious UGB among users of non-steroidal anti-inflammatory drugs (NSAIDs) and acetylsalicylic acid (ASA) were 3.91 (95% CI, 2.03--7.52) and 3.00 (95% CI, 0.94--9.54), respectively. Conclusion. H. pylori infection increases the risk of SSRI-related serious UGB. [ABSTRACT FROM AUTHOR]
– Name: Abstract
  Label:
  Group: Ab
  Data: <i>Copyright of Scandinavian Journal of Gastroenterology is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edb&AN=64002589
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3109/00365521.2011.580100
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 6
        StartPage: 1039
    Subjects:
      – SubjectFull: Fyn (Denmark)
        Type: general
      – SubjectFull: Denmark
        Type: general
      – SubjectFull: Serotonin uptake inhibitors
        Type: general
      – SubjectFull: Gastrointestinal hemorrhage
        Type: general
      – SubjectFull: Helicobacter pylori infections
        Type: general
      – SubjectFull: Nonsteroidal anti-inflammatory agents
        Type: general
      – SubjectFull: Case studies
        Type: general
      – SubjectFull: Aspirin
        Type: general
      – SubjectFull: Disease risk factors
        Type: general
    Titles:
      – TitleFull: Helicobacter pylori and risk of upper gastrointestinal bleeding among users of selective serotonin reuptake inhibitors.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Dall, Michael
      – PersonEntity:
          Name:
            NameFull: Schaffalitzky de Muckadell, Ove B.
      – PersonEntity:
          Name:
            NameFull: Møller Hansen, Jane
      – PersonEntity:
          Name:
            NameFull: Wildner-Christensen, Mette
      – PersonEntity:
          Name:
            NameFull: Touborg Lassen, Annmarie
      – PersonEntity:
          Name:
            NameFull: Hallas, Jesper
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: Sep2011
              Type: published
              Y: 2011
          Identifiers:
            – Type: issn-print
              Value: 00365521
          Numbering:
            – Type: volume
              Value: 46
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Scandinavian Journal of Gastroenterology
              Type: main
ResultId 1